SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Neurocrine Biosciences Files SEC Form

Neurocrine Biosciences submits filing to SEC. No details disclosed.

NBIX

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.